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Background
Myocarditis is an inflammatory cardiac disease with a
wide range of symptoms and various etiologies. The diag-
nostic workup and the treatment of myocarditis remain
highly controversial. Therefore, there is a high demand
for reliable animal models. Experimental autoimmune
myocarditis (EAM) represents a model of human myo-
carditis and heart failure. In this study we investigated
the histological, functional and clinical presentations of
EAM induced by different immunization schemes.
Methods
Male young Lewis rats were divided into 5 groups immu-
nized by porcine myocardial myosin: 1 mg subcutaneously
(SC) on day 0 and 7; 0.25 mg subcutaneously into rear foot-
pads (RF) on day 0; 0.5 mg RF on day 0; and 1 mg RF on
day 0; and a sham group, injected with a vehicle solution
without myosin into the RF on day 0. Rats were sacrificed
on day 21 after assessment of left ventricular (LV) function
by cardiac magnetic resonance imaging and cardiac cathe-
terization under isoflurane anesthesia. The ventricle weight
was measured and the location, type and degree of myocar-
dial inflammatory infiltrates were determined by conven-
tional histology and immunohistochemistry (CD 68).
Results
Rats immunized in the RF showed a mortality of 20%,
20% and 44% for the 0.25 mg, 0.5 mg and 1 mg myosin
doses respectively, while the SC group and the RF sham
group yielded a mortality of 0%. Morbidity as defined
by inflammatory infiltrates on HE staining was 22% in
the SC immunized rats, 0% in the RF sham group and
100% in all actively RF immunized groups. Histologically
we observed macrophage-rich inflammatory infiltrates in
both ventricles. All RF groups immunized with myosin
showed augmented relative ventricle weight and spleen
weight, increased LV end-diastolic pressure, reduced LV
developed pressure and reduced LV ejection fraction,
without any dose-dependend effect.
Conclusions
Subcutaneous immunization into the neck and flanks
failed to induce a reproducible EAM, while RF adminis-
tration of myosin reliably led to EAM. Low-dose RF
myosin application induces the complete histological and
clinical picture of EAM, associated with lower mortality,
non-specific symptoms and animal distress.
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